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Background: Considerable evidence supports the concept of active communication between the nervous and
immune systems. One class of such communicators are the neuropeptides (NPs). Recent reports have highlighted
the antimicrobial activity of neuropeptides, placing them among the integral components of innate immune
defense. This study examined the action of four human neuropeptides: calcitonin gene-related peptide (CGRP),
neuropeptide Y (NPY), substance P (SP) and somatostatin (SOM), which are accessible in the upper respiratory tract,
against two human-specific respiratory pathogens. We studied: (i) neuropeptide-mediated direct antibacterial
activity exerted against Moraxella catarrhalis and nontypeable Haemophilus influenzae, and (ii) indirect
immunomodulatory role of these neuropeptides in the neutrophil-mediated phagocytosis of indicated pathogens.
Results: We found that 100 micromolar concentrations of CGRP, NPY, SP, and SOM effectively permeabilized
bacterial membranes and showed (except SOM) bactericidal activity against both pathogens. SOM acted only
bacteriostatically. However the killing efficacy was dependent on the bactericidal assay used. The rank order of
killing NP effect was: NPY ≥ CGRP > SP >> SOM and correlated with their potency to permeabilize bacterial
membranes. The killing and permeabilization activity of the analyzed NPs showed significant correlation with
several physicochemical properties and amino acid composition of the neuropeptides. M. catarrhalis was more
sensitive to neuropeptides than nontypeable H. influenzae.
The immunomodulatory bimodal effect of physiological concentrations of CGRP, NPY, and SP on the phagocytic
function of human neutrophils against M. catarrhalis and H. influenzae was observed both in the ingestion
(pathogen uptake) and reactive oxygen species generation stages. This effect was also dependent on the distinct
type of pathogen recognition (opsonic versus nonopsonic).
Conclusions: The present results indicate that neuropeptides such as CGRP, NPY, and SP can effectively participate
in the direct and indirect elimination of human-specific respiratory pathogens. Because the studied NPs show both
direct and indirect modulating antimicrobial potency, they seem to be important molecules involved in the innate
host defense against M. catarrhalis and nontypeable H. influenzae.
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Central nervous system-mediated regulation of immun-
ity occurs through systemic, regional and local routes.
The peripheral nervous system provides a first line of
defense at local sites through the release of neuropep-
tides (peptide neurotransmitters) from sensory nerves
[1]. Sensory neuropeptides such as calcitonin gene-
related peptide (CGRP) and substance P (SP) as well as
autonomic neuropeptide Y (NPY) and somatostatin
(SOM) are widely distributed throughout the nervous
system [2]. Numerous reports highlighted their role as
bioactive molecules that exert immunomodulatory
effects on innate and adaptive immune responses. The
majority of the responses involve: (i) modulation of cyto-
kine release by lymphocytes, monocytes/macrophages,
and dendritic cells [3-5], (ii) regulation of lymphocyte and
dendritic cells adhesion and activation [3,6], (iii) modulation
of phagocytosis process [7,8], and (iv) modulation of inflam-
matory response [9].
Unlike the lower respiratory tract, the upper human
airways are richly innervated [10]. SP and CGRP-
containing nerves are present beneath and within the
epithelium, around blood vessels and sub-mucosal
glands and within the bronchial smooth-muscle layer
[11]. Numerous nerves (with SP and CGRP) are located
within the mucosal lining of the middle ear cavity [12].
Nasal mucosa is densely innervated by fibers containing
NPY, SP, and CGRP [13,14]. The potential role of SP and
CGRP in the pathogenesis of microbial-induced/asso-
ciated airway diseases such as otitis media with effusion
or chronic obstructive pulmonary disease has been pos-
tulated [15,16]. Airway lymphoid organs such as lymph
nodes and tonsils receive both autonomic/sympathetic
and sensory peptidergic innervations [10]. Interestingly,
NPY, SP, and CGRP can be synthesized and released also
from the immune cells such as lymphocytes or mono-
cytes/macrophages [17-19]. Due to their cationic charge
at neutral pH, low molecular mass (<10 kDa), and
amphipathic properties, neuropeptides interact with the
negatively charged surface of the microbial membrane
resulting in membrane disruption and direct killing of
the target cell [20]. Similarities between the NPs and the
endogenous antimicrobial peptides led to the discovery
of NPs antimicrobial activity directed against various
bacteria and fungi [21-23], and place neuropeptides
among factors that are capable of forming the local bar-
riers of defense against pathogens.
Moraxella catarrhalis and nontypeable Haemophilus
influenzae are important human-restricted respiratory
tract pathogens that may occasionally cause invasive dis-
eases [24,25]. They are both predominant etiological fac-
tors of otitis media and form biofilms in children with
recurrent or chronic otitis media [26]. They both com-
monly colonize the lower airways of patients withchronic obstructive pulmonary disease, thus contributing
to its pathogenesis [27,28]. Both species asymptomati-
cally colonize the pharyngeal mucosa, a port of pathogen
entry, and are present in nasopharyngeal secretions
[29,30]. Colonization of host mucosal surfaces is the first
and necessary step in the infectious process. Since the
mucosal surfaces of the upper respiratory tract are richly
innervated, both species are potentially exposed to the
action of released neuropeptides.
This study was designed to elucidate two aspects of
the antibacterial properties of neuropeptides CGRP,
NPY, SP, and partly SOM: (i) the direct activity against
Moraxella catarrhalis and nontypeable Haemophilus
influenzae, (ii) the indirect action through the modula-
tion of neutrophil phagocytosis by determination of bac-
terial uptake and respiratory burst response. We
demonstrated temporary bactericidal activity of NPs as
well as their opposite immunomodulatory action with
reference to both studied critical phagocytic functions of
neutrophil response against human-restricted respiratory
pathogens.
Methods
Neuropeptides, reagents, and media
Calcitonin gene related peptide (α-CGRP), neuropeptide
Y (NPY), substance P (SP), and somatostatin (SOM)
were purchased from TOCRIS bioscences (Ellisville,
MO, USA), NPY amino acid fragment NPY18-36 (NPYf)
was bought from Sigma Chemicals (St Louis, MO, USA).
All neuropeptides were dissolved in 0.01% (v/v) acetic
acid containing 0.1% human serum albumin (Sigma) and
stored at – 20°C in working stock solutions at concen-
tration of 10−3 M. Other reagents and supplies such as
acridine orange, hemin, luminol, β-nicotinamide adenine
dinucleotidem (NAD), o-nitrophenyl-β-D-galactopyranosid
(ONPG), phorbol myristate acetate (PMA), polymyxin B
sulfate salt, and trypan blue were from Sigma (Steinheim,
Germany). Other reagents were: ficoll 1.115 g/ml (Aqua-
Med, Poland), FITC (Thermo Scientific, Rokford, USA),
fMLF (Fluka, Switzerland), TSB – tripticasein soy broth
(BIOCORP, Poland), BHI – brain heart infusion broth
(Merck, Germany), HAEM chocolate plates (OXOID,
Germany), agar-agar (Fluka, Spain), NaPB–1% BHI, so-
dium phosphate buffer (pH 7.4) containing 1% BHI (w/v);
HBSS buffer with Ca++and Mg++ (PAA, Austria), heat
inactivated fetal bovine serum (HiFBS), GIBCO BRL.
Bacterial strains
M. catarrhalis ATCC 25238 and H. influenzae ATCC
49247 strains were used. Two clinical nasopharyngeal
isolates of Moraxella catarrhalis (Mc5, Mc6) and non-
typeable Haemophilus influenzae (NTHi3, NTHi6) were
also included in some experiments. In ONPG assay,
Escherichia coli ML-35p a lactose permease-deficient
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tivity (from dr Timothy Starner) was used. The clinical
isolates were obtained from Laboratory of Bacteriology
of the Silesian Centre of Pediatrics in Wroclaw, Poland.
The final identification of M. catarrhalis was made using
a standardized commercial identification system API-
NH (Bio-Merieux, France). H. influenzae strains were
identified by both X and V factor requirements, growth
on chocolate agar but not on blood agar. The absence of
bexA gene was confirmed by PCR capsular genotyping
using H. influenzae type b as positive control [31]. NTHi
strains were cultivated on HAEM chocolate agar plates
or in BHI broth supplemented with hemin and NAD at
final concentrations of 15 μg/ml. M. catarrhalis strains
were grown in BHI. E. coli ML-35p was maintained on
TSB. All Mc and NTHi strains were grown at 37°C with
5% CO2. The strains were stored in relevant medium
containing 16% glycerol at −70°C.
Antimicrobial assays
To evaluate antimicrobial properties of purified neuro-
peptides two assays were used: (i) a radial diffusion assay
[32] and (ii) a slightly modified liquid broth assay [33]
referred to as the time kill assay from 0 to 1.5 h.
For the radial diffusion assay a mid-log phase bacteria
were diluted to the concentration of ~ 1–2 × 106 CFU/ml
in 10 ml of melted and cooled to 42°C, 1% agarose (w/v,
molecular biology grade) in 10 mM sodium phosphate con-
taining 1/100 dilution of full strength BHI and 0.02% (v/v)
Tween 20 (Sigma). After vigorous mixing, the bacteria in
the agarose were poured onto Petri plate forming under-
layer in which 3 mm diameter sterile wells were cut. The
wells were filled with serially diluted neuropeptides (5 μl) at
concentrations ranging from 10−6 M to 10−3 M and plates
were incubated for 3 h at 37°C to allow peptide diffusion.
The plates were then overlaid with 10 ml of the buffered
1% agarose containing 6% BHI (w/v) and allowed to
harden. After overnight incubation at 37°C the diameters of
inhibition zones were measured and antimicrobial activities
of NPs expressed as minimal inhibitory concentrations
(MIC) were evaluated. The MIC value was determined as
the x-axis intercept obtained from the relationship be-
tween the diameter of radial diffusion zones versus NP
concentration. Resistance was defined for MIC greater
than 500 μg/ml [22]. Polymyxin B was used as a positive
control.
For the time kill assay from 0 to 1.5 h, overnight cul-
tures of Mc and NTHi were inoculated into new medium
and incubated under the relevant conditions until early
log-phase (OD600 = 0.25–0.3). The bacteria were diluted in
10 mM sodium phosphate buffer, NaPB, (pH 7.4) contain-
ing 1% (w/v) BHI to obtain ~2 x 106 CFU/ml. The
bacterial suspensions were incubated in the presence of
10 μM and 100 μM concentrations of SP, CGRP, NPY, andSOM in a final volume of 100 μl NAPB-1% BHI, for 0, 0.5
and 1.5 h at 37°C in water bath. After each time of incuba-
tion the suspensions were 10-fold serially diluted with
10 mM NaPB-1% BHI and 20 μl aliquots were plated in
triplicate on BHI (M. catarrhalis) or HAEM (H. influen-
zae) agar plates. The plates were incubated overnight at
37°C in 5% CO2 conditions. Simultaneously, the incuba-
tion of bacteria in the presence of an appropriate diluent
was included for positive control of bacterial growth. The
colony counts and CFU/ml were calculated next day. The
bactericidal activity of neuropeptides was expressed as
survival ratios determined as the numbers of CFU after
neuropeptide incubation divided by the numbers of CFU
estimated from a control plate (time 0). All antimicrobial
assays were performed at least two times in triplicate.
Membrane permeability assay
To measure the activity of neuropeptides in permeabilization
of bacterial membrane, the ONPG-mediated β-galactosidase
microplate assay was used. Permeabilization was mea-
sured using E. coli ML-35 with constitutive cytoplasmic
β-galactosidase activity as previously described [34,35].
Briefly, 18 h E. coli ML-35p in TSB was recultivated in
TSB until mid-log phase (OD600 = 0.5). Flasks were put
on ice for 20 min, and 2 ml of bacterial suspensions
were transferred to Eppendorf tubes, washed twice with
10 mM sodium phosphate NaPB (pH 7.4) and sus-
pended in NaPB to OD600 = 0.5. Bacterial suspensions
were diluted in NaPB to obtain 106 CFU/ml and incu-
bated on the flat bottomed 96-well plate (NUNC,
Denmark) with various concentrations (10−6–10−4 M)
of CGRP, SP, SOM, NPY, and NPY18–36 diluted in NaPB
with 3 mM ONPG as β-galactosidase substrate in the
final volume of 150 μl. Microplates were incubated at
37°C for 1.5 h and optical densities were measured
every 15 minutes at λ=405 nm (spectrophotometer
Opsys MR Dynex Technologist). All the assays were
performed in triplicate. Two positive controls were
used: polymyxin B at the final concentration of 1 μg/ml
as an established model of peptide permeabilizing ac-
tion, and 20% chloroform (v/v). Chloroform, as an indi-
cator of extensive permeabilization (arbitrarily defined
as maximal) which led to the maximal OD increase,
was used in order to quantitatively calculate and com-
pare the permeabilizing strength of studied NPs. We
estimated their molar concentration defined as the in-
ducible dose (ID50) that caused 50% increase in OD cal-
culated with reference to the chloroform-inducible
maximum, 45 min after the beginning of measurement.
The molar concentration of NP that caused such in-
crease was extrapolated from a linear portion of NP ti-
tration curve. Negative controls constituted bacteria
incubated with NaPB and ONPG but without
neuropeptides.
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Polymorphonuclear leukocytes (PMNs) from healthy
young adult volunteers were isolated from venous blood
samples anticoagulated with Lithium-heparin (7.5 ml) by
ficoll (Aqua-Med, Poland) density gradient centrifuga-
tion (2000 rpm/30 min), followed by hypotonic lysis of
erythrocytes with a lysing buffer (0.83% NH4Cl, 0.1%
KHCO3, EDTA, pH 7.4). After two washes (1400 rpm/
10 min) in PBS, PMNs were resuspended to the final
concentration of 107 cells/ml in phagocytic buffer: HBSS
with Ca++ and Mg++ supplemented with 1% HiFBS. The
purity of granulocyte suspensions was checked using
15 μg/ml of acridine orange. The cell suspensions con-
taining at least 95% of PMNs were used for the phago-
cytosis assays described below. Cell viability was
determined to be> 97% by trypan blue staining. Isolated
PMNs were kept for 30 min at 37°C and 5% CO2 until
used.
The study was approved by the Research Ethics Com-
mittee of the Medical University of Wroclaw and
informed consent was obtained from all volunteers.
Phagocytosis assay
i. Labeling of bacteria with fluorescein isothiocyanate
(FITC): FITC-labeled bacteria were prepared as
described previously [36]. Briefly, bacteria M.
catarrhalis ATCC 25238 and NTHi ATCC 49247
from overnight cultures were harvested, suspended
into PBS and adjusted to an A600 of 1 (OD = 1)
corresponding to ~ 2 × 109 CFU/ml. Heat-killed
bacterial suspensions at OD = 1 were labeled with
1 mg/ml of FITC at 0.05 M carbonate/bicarbonate
buffer (pH 9.5), for 30 min at 37°C with gentle
mixing in the dark. FITC-conjugated bacteria were
washed 3 times by centrifugation with cold
carbonate/bicarbonate buffer in order to remove
the excess of FITC, and finally resuspended in
HBSS-Ca++Mg++ at 1/10 of original volume.
ii. Opsonization: FITC-labeled bacteria in HBSS-
Ca++Mg++ were opsonized with post-immunized 10%
heat-inactivated pooled murine antisera for 30 min at
37°C with rotation, followed by washing with PBS.
Antisera from mice immunized with whole bacteria
(Mc or NTHi) had whole cell ELISA titers of specific
IgG antibodies, which were> 1: 10,000.
iii. Bacterial uptake: 50 μl of PMNs (107 cells/ml) in
phagocytic buffer was mixed with 10 μl of FITC-
labeled targets supplemented with 5% HiFBS and
10−8 M concentration of NPs in a final volume of
100 μl and incubated at 37°C for 30 min with gentle
agitation on rotary shaker (100 rpm). Phagocytosis
was terminated by placing the samples briefly on ice.
Parallel controls were kept on ice to block endocyticuptake of the targets. Cells were treated with
0.2 mg/ml of trypan blue solution to quench
extracellular fluorescence [37]. Each assay was
performed at least three times in duplicate. The
concentration of NPs indicated as the most potent
within the range 10−12 to 10−8 M, was chosen on the
basis of preliminary experiments.
iv. Flow cytometric analysis: Fluorescence of FITC-
labeled bacteria ingested by granulocytes (FITC-
positive granulocytes) was measured by FACS
Calibur (Becton Dickinson). Before analysis the
samples were diluted 1:5 in cold HBSS-Ca++Mg++.
PMNs were distinguished from other leukocytes by
gating on forward- and sideward-scatter signals,
then this population was analyzed for green
fluorescence in the FL1 channel. 15,000 events were
measured to assess the percentage of phagocytizing
neutrophils and the mean fluorescence intensity
(MFI) of PMNs. Data were obtained using Becton
Dickinson software and further analysis was
performed using WinMDI 2.8 software. Data were
expressed as the percentage of phagocytosis in
reference to control values (100% = phagocytosis
without NPs) or as the MFI of PMN.
Detection of ROS formation by chemiluminescence
Reactive oxygen species (ROS) formation by PMNs was
measured using luminol-dependent chemiluminescence
assay (CL) in white flat-bottom 96-well microplates
(NUNC, Denmark). The reaction mixture of total volume
200 μl in each well contained: 100 μl of PMN suspension
in HBSS–Ca++Mg++ (105 cells/well), 40 μl of luminol
(50 μM/well), 40 μl of fMLP (0.2 μM/well), 20 μl of par-
ticular NP (in the range 10−12–10−8 M/well). In other
experiments, the respiratory burst was triggered by phago-
cytosis of 40 μl heat killed (56°C/30 min) M. catarrhalis
ATCC 25238 or H. influenzae ATCC 49247 at concentra-
tion of ½ of OD600 = 1 or OD600 = 1, respectively. In these
experiments, only the most potent NPs concentration
(10−8 M) was used. The PMA stimulus at 0.1 μM final
concentration was used as positive control of the relevant
oxidative stress. The CL kinetics was measured at con-
stant 37°C temperature using luminometer (Microlumat,
LB96P, Berthold) and recorded as relative light units
(RLU). Measuring conditions for fMLP were: interval
(46 s), run time (up to 30 min). The conditions for bacter-
ial and PMA stimulation were: interval (83 s), run time
(up to 60 min). The maximal value of CL response curve
was expressed as peak height (PHCL) for fMLP stimulant.
In other cases the area under chemiluminescence curve
(AUCCL) was calculated [38]. Each sample was run in trip-
licate and the values were averaged. Relative CL was cal-
culated as: mean AUCCL of sample / mean AUCCL of control ×
100%. Results were expressed as mean ± SD. After
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> 93% using trypan blue exclusion.Relationship between the direct antibacterial activity of
peptides and their physicochemical characteristics
The relationship of neuropepeptide activities with their
different physicochemical properties and amino acid
composition were correlated using Spearman’s rank co-
efficient. The antibacterial properties of the analyzed
neuropeptides were expressed as survival ratios after
1.5 h of bacterial exposure whereas permeability proper-
ties were measured by peptide concentration (expressed
in μM) that caused 50% increase (ID50) in the membrane
permeability (measured by OD) after 45 minutes from
the beginning of the experiment. In the analyses we also
included the antibacterial properties (expressed as MIC
in μM) of neuropeptides/peptides published by other
scientists [21,23]. The data from experiments performed
on different bacteria but for the same or overlapping set
of peptides were min-max normalized to be included in
one meta-analysis. Ten physicochemical properties
deduced from sequences of the peptides were consid-
ered. Isoelectric point was calculated based on the stand-
ard iterative algorithm used in ExPASy Proteomics
Server [39]. Appropriate amino acid indices downloaded
from ExPASy Proteomics Server were applied to calcu-
late polarity [40], hydropathicity [41], transmembrane
tendency [42], and conformational parameter for α-helix
and β-sheet [43]. Maximum hydrophobic moment was
calculated as implemented in hmoment from EMBOSS
package [44]. The NPs composition of amino acids clas-
sified to four different physicochemical groups: non-
polar (A, C, F, G, I, L, M, P, V, W), polar uncharged (N,
Q, S, T, Y), basic (H, K, R), and acidic (D, E) was
analyzed.Statistical analysis
Normality and homogeneity of variance assumptions
were checked using Shapiro-Wilk’s and Levenea’s test,
respectively. For multiple comparisons, data were ana-
lyzed using one-factor analyses of variance (ANOVA)
and were followed by post hoc effects (Tuckey’s test or
Duncan’s test). Spearman’s rank correlation coefficients
were used for the relationship assessment. Results were
expressed as means ± SEM of the n independent experi-
ments performed in triplicate and containing cells from
separate donors. For the comparison of ROS generation
or phagocytic uptake by bacteria-stimulated PMNs in re-
sponse to neuropeptides, the data were normalized to a
baseline control value (without NPs) of 100%. A P value
< 0.05 was used to assess the significance of all statis-
tical analyses. All the analyses were performed with
STATISTICA 9 software.Results
Rank order of permeabilizing potency of neuropeptides
In order to determine the potency of CGRP, NPY, its
truncated fragment NPY18–36, SOM and SP on perme-
ability of the gram-negative bacteria membrane, a model
microorganism, E. coli ML-35p and β-galactosidase assay
were used. The time-dependent increase in absorbance
at 405 nm in this assay is the result of permeability of
both the inner and outer bacterial membranes, con-
firmed by the intracellular influx of the extracellular dye
ONPG that is hydrolyzed by constitutively expressed β-
galactosidase [34]. In each set of experiments, polymyxin
B was used as the first positive control and the estab-
lished model of peptide permeabilizing action. The sec-
ond positive control employed chloroform which caused
an extensive bacterial membrane permeabilization, and
led to the maximal OD increase.
Tested neuropeptides displayed an activity in bacterial
membrane permeability in a time- and dose-dependent
manner (Figure 1). An examination of the neuropeptide-
induced ONPG influx, as a function of time indicates
that the shapes of permeability profiles were similar
whereas time courses of the maximal permeability for all
tested NPs used at highest (100 μM) concentrations
were slightly different. CGRP induced the maximal OD
increase at 50 min, NPY and NPY18–36 at 75 min,
whereas SP and SOM at 90 min from the beginning of
the reaction, followed by a gradual decrease in OD over
time (not shown). Concentrations of 10 μM exerted per-
meabilizing potency for all tested neuropeptides except
SOM, and induced a maximal OD increase at ~ 90 min
of ONPG influx (only for NPY18–36 it was ~ 75 min). To
quantitatively calculate the permeabilizing potency of
NPs, we estimated their molar concentration defined as
the inducible dose (ID50) that caused 50% increase in
OD calculated in reference to the chloroform-inducible
maximum at 45 min. The molar concentration of NPs
calculated for different times and raw permeability
values led to the same final conclusion. The neuropep-
tide concentrations needed for 50% ONPG influx
are presented in Table 1. Their permeability potency
against E. coli ML-35p increased in the following order:
SOM<< SP<NPY ≤ CGRP<NPY18–36. These find-
ings demonstrate that the four studied NPs efficiently
permeabilized bacterial membranes of the model micro-
organism E. coli ML-35p with NPY18–36 being the most
effective and SOM the least.
Killing efficacy of M. catarrhalis and H. influenzae by
CGRP, NPY, SP, and SOM
The permeabilizing potency of peptide may sometimes
not correlate with its lethal effect. Moreover, there are
some discrepancies concerning the direct antibacterial















































































































































Figure 1 Permeabilizing potency of neuropeptides against E.coli ML-35p, determined by β-galactosidase assay with ONPG as its
substrate. Bacteria at 106 CFU/ml were incubated at 37°C for 90 min in the presence of the indicated micromolar concentrations of
neuropeptides: neuropeptide Y (NPY), fragment of neuropeptide Y (NPYf = NPY18–36), calcitonin gene related peptide (CGRP), substance P (SP),
and somatostatin (SOM). In negative controls, bacteria incubated in neuropeptide-free NAPB containing 1/100 of TSB showed no net hydrolysis of
ONPG. Polymyxin B (PMB) at 1 μg/ml was included as a positive control. The representative curves of at least three independent experiments are
presented.
Augustyniak et al. BMC Immunology 2012, 13:24 Page 6 of 17
http://www.biomedcentral.com/1471-2172/13/24their activity against clinical respiratory pathogens has
not been elucidated so far. Thus in the next step we
compared the killing efficacy of effective permeabilizing
neuropeptide doses (10 and 102 μM) against isolates of
M. catarrhalis and H. influenzae using two methods:
(i) a radial diffusion assay and (ii) a time kill assay fromTable 1 Parameter defining NP-induced intracellular







*ID50 (inducible dose) - dose of NP that caused 50% increase in OD calculated
in the reference to the chloroform-inducible maximum at 45 min of
experiment. The values carry a standard error of approximately.0 to 1.5 h. In the radial diffusion assay CGRP, NPY,
NPY18–36, SP, and SOM were tested against M. catarrha-
lis ATCC 25238, H. influenzae ATCC 49247, and four
clinical respiratory isolates of M. catarrhalis (Mc5, Mc6)
and non-typeable H. influenzae (NTHi3, NTHi6). In this
assay, within used NPs ranges from 1 μM to 102 μM, all
tested M. catarrhalis and H. influenzae strains were sus-
ceptible only to the truncated form of neuropeptide Y
(NPY18–36). M. catarrhalis strains were generally two/
three-fold more susceptible (MICs from 8 to 12.5 μM)
than H. influenzae (MICs from 25 to 40 μM). In order to
test if higher doses of NPs (apart from NPY18–36) can be
bactericidal, two additional concentrations, 5 x 102 μM
and 103 μM were used. Weak inhibition zones were
observed for four NPs at indicated concentrations. CGRP,
NPY, SP, and SOM exhibited no antimicrobial activity in
the radial diffusion assay as their MICs for all 6 isolates of
both M. catarrhalis and H. influenzae were higher than
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SOM) which corresponded to 500 μg/ml, defined as the
cut off for antimicrobial neuropeptide activity [22,23].
The similar results were obtained for additional tested
isolates of both species (data not shown). In control
experiments all tested M. catarrhalis and H. influenzae
isolates showed susceptibility to polymyxin B within a
range from 0.39 μg/ml to 3.12 μg/ml and from 1.56 μg/
ml to 6.25 μg/ml, respectively.
In contrast to the radial diffusion assay, three studied
neuropeptides (except SOM) exerted killing effect in the
time kill assay from 0 to 1.5 h. As illustrated on survival
plots (Figure 2). M. catarrhalis strains were in general
more susceptible to the tested neuropeptides than H.
influenzae. Use of 100 μM concentration of CGRP, NPY,
and SP against M. catarrhalis resulted in killing of both
tested Mc strains that occurred in a time-dependent
manner. NPY killed more than 95% of bacterial cells of
both strains after 0.5 h and nearly 99% of them after
1.5 h. CGRP was less potent than NPY in killing M. cat-
arrhalis. In its presence ~40% of Mc5 and more than
20% of Mc6 cells were killed after 0.5 h incubation, and


















































Figure 2 Neuropeptide-mediated killing of M. catarrhalis (Mc) and no
incubated at NaPB - 1% BHI (v/w) containing 100 μM concentration of NPY
plated on BHI agar. The data are expressed as mean survival ratios ± SEM frafter 1.5 h. The lethal activity of SP against Mc5 and
Mc6 strains was similar. SP was bactericidal for~ 43% of
Mc5 cells and 52% of Mc6 cells after 1.5 h, whereas after
0.5 h incubation nearly 100% of both cultures survived.
Interestingly 100 μM SOM elicited bacteriostatic activity
for both Mc strains. There was no M. catarrhalis growth
inhibition when all NPs were used at 10 μM (data not
shown). All neuropeptides displayed a similar pattern of
killing activity against H. influenzae strains NTHi3 and
NTHi6. Similarly to M. catarrhalis, no growth inhibition
was observed for any NPs used at a 10 μM concentra-
tion. The evaluation of NTHi survival revealed that in
the presence of the most potent 100 μM NPY ~75% of
NTHi3 and NTHi6 were killed after 1.5 h incubation
whereas after 0.5 h NPY led to the death of up to 20% of
the bacteria. 100 μM SP was able to reduce the bacterial
viability of both strains by at least 30% after 1.5 h. CGRP
killed ~ 30% of NTHi6 after 0.5 h and ~ 60% after 1.5 h,
whereas for NTHi3 its effect was bacteriostatic. The in-
cubation of Mc and NTHi strains without neuropeptides
(controls) showed an approximate 1.5-fold increase of
bacterial growth after 1.5 h of incubation. Extension of

















































ntypeable H. influenzae (NTHi). Bacteria at ~ 2 × 106 CFU/ml were
, CGRP, SP, and SOM for 0.5 and 1.5 h. Serially diluted aliquotes were
om two independent experiments performed in triplicate.
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mediated bactericidal activity and in a gradual increase
in bacterial growth (data not shown), indicating that
NPs are efficient in killing mucosal pathogens within a
short time period.
Thus, apart from bacteriostatic SOM, 100 μM concen-
tration of CGRP, NPY, and SP are bactericidal against
clinical isolates of M. catarrhalis and H. influenzae. NP-
mediated killing occurred within 1.5 hours of exposure
in a time-dependent manner. These data also indicate
that the rank order of bactericidal activity of 100 μM
NPs was similar to that of the permeabilizing potency
with NPY > CGRP ≥ SP >> SOM. Overall, these data
indicate that CGRP, NPY, SP and SOM at micromolar
concentrations have the capacity, respectively to kill high
numbers of mucosal pathogens and inhibit their growth
within short time period.
Relationships between the direct antibacterial activities of
peptides and their physicochemical characteristics
Some relationships between antimicrobial effect of the
endogenous peptides and their amino acid composition
or physicochemical properties have been reported [45].
Most of these peptides form cationic amphipathic sec-
ondary structures, typically α-helices and β-sheets with
high hydrophobicity. In order to assess these relation-
ships quantitatively for the analyzed neuropeptides, we
correlated their permeability effectiveness and killing ef-
ficacy expressed as survival ratios with their different
physicochemical properties and amino acid composition.
We also compared the results with data for other pep-
tide sets with experimentally determined antimicrobial
activity gathered from papers [21,23]. Spearman’s rank
correlation coefficients between antibacterial activity of
peptides and their physicochemical characterization for
particular experiments were presented in Figure 3,
whereas coefficients shown in Table 2 were calculated
for min-max normalized data from several experiments
performed on different bacteria and for the same or
overlapping set of peptides.
The correlations obtained for the peptides studied in
this paper were very similar, irrespective of the anti-
microbial measure: effectiveness of permeabilization or
bacterial killing (Figure 3). The antimicrobial activity
increased significantly with length, molecular mass, po-
larity, hydrophobic moment, and content of acidic resi-
dues in the peptides whereas it decreased with their
tendency to form transmembrane domains, content of
non-polar amino acid residues and hydropathicity
(Table 1). However, the antibacterial potency for the sets
of peptides taken from [21] increased significantly with
isoelectric point, charge, tendency to form transmem-
brane domains and α-helices or β-sheet structures
whereas decreased with polarity (Table 1). According todata by [23], peptides with larger charge, hydropathicity
and tendency to form β-sheet structures showed higher
activity against bacteria (Table 1).
NP-mediated modulation of bacterial uptake by PMNs
NP-induced phagocytosis may be triggered as a result of
both non-specific and specific ligand-receptor inter-
action and may depend on the nature of the engulfed
pathogen [8,46]. We investigated whether SP, NPY, and
CGRP exert a modulating role in the uptake of mucosal
pathogens by freshly isolated human granulocytes, and
whether such modulation involves a distinct type of
pathogen recognition (opsonic versus nonopsonic phago-
cytosis). As expected, precoating M. catarrhalis with 10%
antiserum significantly enhanced the phagocytic capacity
of PMNs (MFI 1411.2 ± 111.8 (SEM); n = 6) in compari-
son to nonopsonic conditions (MFI 289.7 ± 51.5; n = 6;
p< 0.004) and respectively nearly 97% ± 0.49% versus
83% ± 3.9% of FITC-positive granulocytes (n = 6; p< 0.02)
were detected by FACs. Uptake of H. influenzae revealed a
similar 4-fold increase under opsonic versus non-opsonic
conditions (Figure 4A). The observed opsonic phagocytic
potency of PMNs against both mucosal pathogens was next
markedly improved in the presence of NPs (Figure 4B). As
shown in Figure 4C the enhancement of serum opsonized
M. catarrhalis or H. influenzae uptake was from ~18% to
~ 50% and from ~ 11% to nearly 42%, respectively, depend-
ing on the tested NP with evident potency of NPY ≥ CGRP
> SP. These results suggest that the stimulatory effects of
NPY, CGRP, and SP on PMN uptake seem to be additive to
the opsonin action. Figure 4B and C demonstrate that,
when nonopsonized M. catarrhalis or H. influenzae cells
were ingested by PMNs, their uptake in the presence of
neuropeptides remained unchanged or was slightly dimin-
ished (up to 15% inhibition) compared to non-stimulated
positive control indicating no effect or slightly inhibitory ac-
tion. Moreover, as expected, the differences in magnitude
of the modulating properties of NPs were also dependent
on the PMN source thereby reflecting the actual physio-
logic conditions and vital responsiveness of PMNs from
various donors. We postulate from this finding a stimulat-
ing action of the NPs, which depends on the phagocytic
recognition of the studied mucosal pathogens and is con-
nected with opsonin presence.
NP-mediated modulation of ROS metabolism by PMNs
The luminol-dependent chemiluminescence (CL) re-
sponse was used to measure the bactericidal activity of
PMNs. Since the kinetics of the CL response triggered
by fMLF and phagocytosable bacteria or PMA, including
both the magnitude and the temporal pattern were quite
different, we used in calculations PHCL and AUCCL, re-
spectively. In preliminary experiments, in order to choose



























































permeability in E. coli ML-35p (this paper)
Moraxella catarrhalis Mc6 (this paper)
Moraxella catarrhalis Mc5 (this paper)
Haemophilus influenzae NTHi3 (this paper)
Haemophilus influenzae NTHi6 (this paper)
Figure 3 Spearman’s rank correlation coefficient between antibacterial activity of peptides and their physicochemical characterization.
An individual symbol represents the result of a given experiment. Experiments presented in this paper involved: calcitonin gene-related peptide,
neuropeptide Y, fragment of neuropeptide Y (NPYf = NPY18–36), substance P, and somatostatin. Data taken from Kowalska et al. [21] included:
bradykinin, indolicidin, neurotensin, substance P, and substance P antagonist whereas data from El Karim et al. [23] contained: calcitonin gene-
related peptide, neuropeptide Y, substance P, and vasoactive intestinal peptide. For further explanation see Materials and Methods.
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sharp maximum, which was observed within ~5 min of
ROS response, followed by a subsequent decline to the
baseline. The significant stimulatory effects of various
physiological doses of neuropeptides (10−12 M–10−8 M)
on the luminol-dependent CL responses of PMNs acti-
vated by fMLF are shown in Table 3. The amplification of
ROS release, with maximal effect observed at ~5 min of
fMLF exposure, was more potent under lower NP concen-
trations with the rank order of CGRP> SP>NPY. Neu-
ropeptides CGRP, SP, and NPY alone did not activate a
respiratory burst of PMNs. To evaluate whether the NP-
mediated intensification of respiratory burst by PMNs was
more relevant to PMN physiology, the respiratory burst
activity was determined following stimulation byM. catar-
rhalis ATCC 25238 and NTHI ATCC 49247. Additionally,
we explored the question if such modulation involvesdistinct types of pathogen recognition (opsonic versus
nonopsonic). Incubation of human PMNs with opsonized
as well as nonopsonized M. catarrhalis or nontypeable H.
influenzae resulted in substantial ROS generation, peaking
between 35 and 40 min, followed by a gradual decrease.
As shown in Figure 5A, for a representative experiment,
the opsonization with 10% heat inactivated antiserum
increased both the rate and the total production of ROS,
which for both studied bacteria, was approximately 2-fold
higher comparing to nonopsonic stimulation. In this case,
log10 of mean AUCCL ± SEM for opsonized versus nonop-
sonized M. catarrhalis and H. influenzae was 5.71 ± 4.67
versus 5.39 ± 4.47 and 4.99 ± 3.62 versus 4.69 ± 3.3,
respectively. As shown in Figure 5B, only CGRP used at
10−8 M significantly intensified the respiratory burst of
PMNs triggered by phagocytosable M. catarrhalis in the
absence of serum, thus confirming partly the results
Table 2 Spearman’s rank correlation coefficient (with
p-value) between antibacterial activity of peptides and their
physicochemical characterization including data from
experiments carried out in this paper and by other authors
Physicochemical
characteristics
Peptide set analysed in:
this paper [21] [23]
length −0.44 (0.044) −0.33 (0.174) −0.25 (0.555)
molecular mass −0.69 (0.000) −0.42 (0.085) 0.27 (0.515)
isoelectric point 0.31 (0.164) −0.78 (0.000) −0.27 (0.515)
charge 0.32 (0.160) −0.48 (0.043) −0.94 (0.001)
polarity −0.91 (0.000) 0.79 (0.000) 0.32 (0.438)
hydropathicity 0.57 (0.006) −0.14 (0.572) −0.91 (0.002)
transmembrane
tendency
0.82 (0.000) −0.79 (0.000) −0.64 (0.086)
α-helix tendency 0.31 (0.170) −0.58 (0.012) −0.02 (0.954)
β-sheet tendency 0.41 (0.063) −0.66 (0.003) −0.91 (0.002)
maximum hydrophobic
moment
−0.72 (0.000) 0.26 (0.306) 0.32 (0.438)
non-polar residues [%] 0.70 (0.000) −0.13 (0.600) 0.15 (0.726)
polar residues [%] −0.41 (0.063) 0.13 (0.600) −0.15 (0.726)
basic residues [%] −0.23 (0.316) 0.44 (0.065) −0.02 (0.954)
acidic residues [%] −0.79 (0.000) 0.38 (0.123) 0.32 (0.438)
The data from experiments performed on different bacteria but for the same
or overlapping set of peptides’ set were min-max normalized and included in
one analysis. For further explanation see Materials and Methods. Results
significant with p-value< 0.05 were shown in bold.
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differences in the sensitivity of the PMNs responses to the
individual bacterial stimulant as well as interindividual
variation in ROS generation. ROS production by PMNs to
M. catarrhalis was generally more sensitive to NPs than
equivalent response to NTHi. Data obtained for M. catar-
rhalis (Figure 5B) show that the mean AUCCL of PMNs
stimulated with these bacteria was increased in the pres-
ence of SP by 14.2 ± 3.4% (range: 10.3−20.1%, n = 6),
CGRP by 40.5 ± 22.3% (range: 22.7−75.7%, n = 6) and
NPY by 7.5 ± 4.0% (range: 3.5−12.8%, n = 5). The stimula-
tory effect of NPs in the presence of NTHi was relatively
weaker. The mean relative CL increase elicited (4 donors)
was: SP 8.2 ± 5.4 (range: 3.2−17.0%), CGRP 10.4 ± 9.3
(range: 0.0−25.0%) and NPY 2.2 ± 9.3 (range: 0.0−12.7%).
The observed stimulating effect of NPs was not preserved
for both opsonized bacteria (Figure 5B). Under these con-
ditions the relative amounts of ROS were usually dimin-
ished up to 15% below the level of control ROS
production. It indicated an inhibitory rather than stimula-
tory action of CGRP and inhibitory action of NPY during
the response to M. catarrhalis. The similar modulating
tendency of NPs, although not significant, was shown for
NTHi. PMNs without bacteria or those stimulated only
with NPs did not release significant amounts of ROS. Theanalysis of PMA-induced CL in PMNs was included in
each experiment as an internal standard of relevant PMN
activation. A stimulation with PMA always generated the
strongest and slightly biphasic response with usually two
separate maxima (~10 min, and ~25 min) which gradually
decreased. The log10 of mean AUCCL ± SEM calculated
from 0 to 60 min for that soluble and stabile stimulant
was 6.05 ± 4.32 (not shown data from five independent
experiments done in triplicate, using PMNs from 5 blood
donors). Taken together, the presented data suggest that
CGRP and less NPY at physiological concentrations are
modulators of the respiratory burst of PMNs in response
to M. catarrhalis, whereas in the case of nontypeable H.
influenzae these effects are notable for CGRP and SP.
Discussion
Moraxella catarrhalis and nontypeable Haemophilus
influenzae are human-restricted mucosal pathogens that
may potentially be exposed to the action of locally released
neuropeptides. The importance of neuropeptides as the
initial innate defenders seems to be associated with their
direct (bactericidal) and indirect (modulatory) activity.
The findings of the study demonstrate the complex anti-
bacterial activity of neuropeptides CGRP, NPY, SP, and
partially also SOM, against M. catarrhalis and nontype-
able H. influenzae. Initially, we evaluated the direct anti-
bacterial activity of neuropeptides, and found, using
model E. coli ML-35p strain, that CGRP, NPY, NPY18−36
and SP at concentrations of 100 μM and 10 μM, and
SOM at 100 μM are effective permeabilizers. The activity
of NPs was time and dose-dependent with the following
potency order of permeabilization: NPY18−36 > CGRP ≥
NPY > SP >>SOM. This effect was probably the result
of neuropeptide-mediated sequential permeabilization of
the outer and inner membrane of gram-negative bacteria
since such mechanism is dedicated to other endogenous
antimicrobial peptides [34,47].
The permeabilizing activity of peptides sometimes may
not correlate with their killing properties [48]. Thus, our
next experiments aimed at determining the nature of
antibacterial activity of effective permeabilizing NP
doses, more specifically, whether they are bactericidal or
bacteriostatic? We found that 100 μM CGRP, NPY, and
SP exerted bactericidal and time-dependent impact on
the metabolically active M. catarrhalis and H. influenzae
within 1.5 h. This indicated, at micromolar concentra-
tions, their temporary capacity to kill high numbers of
respiratory pathogens. The action of SOM proved, at
the same time, to be bacteriostatic. The following
potency order of bactericidal action was established:
NPY > CGRP ≥ SP >> SOM. In general, neuropeptides
start to kill M. catarrhalis within 0.5 h, whereas the killing
of H. influenzae is slightly delayed in time. Threshold con-
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Figure 4 (See legend on next page.)
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Figure 4 Involvement of various neuropeptides (NPs) used at 10−8 M in the modulation of heat-inactivated serum opsonized and
nonopsonized M. catarrhalis ATCC 25238 (Mc) and H. influenzae ATCC 49247 (NTHi) engulfment by isolated human polymorphonuclear
phagocytes (PMNs) analyzed by flow cytometry. PMNs were incubated with FITC-labeled bacteria for 30 min at 37°C with agitation and
analyses of 15,000 PMNs are presented. Shown is fluorescence signal indicated as geometric mean of the FL-1 signal from the gated sample with
phagocytosing PMNs. (A) Representative FACs dot plot with gated PMNs and representative histograms of phagocytic uptake of serum-
opsonized (black lines) and nonopsonized (grey lines) bacteria by PMNs in the absence of NPs are shown. (B) Histograms represent increased or
decreased endocytic uptake of FITC-labeled opsonized versus nonopsonized targets in the presence of indicated neuropeptides (10−8 M). The
levels of bacteria ingested, indicated by mean fluorescence intensity (MFI) values are shown. Color lines show test samples in the presence of
indicated neuropeptides, grey lines represent bacterial uptake in the absence of neuropeptides. Results are from one experiment representative
of three experiments done with separate blood donors. (C) Data are expressed as the percentage of phagocytosis reported with respect to
control values (100% = phagocytosis without NPs). Values are means ± SEM of at least n = 5 (M. catarrhalis) and n = 3 (H. influenzae) independent
experiments. Differences between control (without NPs) and treatment condition uptake are assigned by asterisks and considered significant if
*p< 0.005 and **p< 0.0005 (one-way ANOVA followed by Tuckey’s post hock test).
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peptide-membrane interactions.
Amounts of NPs regarded as physiological (10−12 to
10−8 M) imply that bactericidal activities of NPs defined
in this study are of only pharmaceutical significance.
Nevertheless, we cannot rule out that neuropeptide levels
may be locally elevated in response to infection or other
inflammatory condition. An example of such neuropep-
tide alteration may be the marked increase of SP expres-
sion in the airways, following respiratory syncytial virus
infection [49]. Additionally, despite the fact that neuro-
peptides are released from nerve endings, they can also be
synthesized in and released from the immune cells such
as lymphocytes, monocytes/macrophages [17-19] as well
as airway epithelial cells [50] or fibroblasts [51]. Therefore,
locally high concentration of NPs, sufficient for bacteri-
cidal activity, is possible under certain inflammatory state
in the respiratory tract.
Ten-fold lower concentration (10 μM) of all NPs was
not effective. Nevertheless, despite the lack of lethal activ-
ity, SOM being an exception, it altered the permeability
barrier of model E. coli ML-35 mutant. Hypothetically,
such an alteration could promote an interaction with final
intracellular targets for a variety of extracellular molecules,
including the neuropeptide itself [47]. In that case, the po-
tential neuropeptide-mediated induction of the bacterial
sensitization to other endogenic (defensins) or egzogenic
(antibiotics) compounds could indirectly contribute to the
local antimicrobial activity of the host or to theTable 3 Neuropeptide-mediated stimulation of fMLF-induced
chemiluminescence
Stimulus ROS release [% of control]
SP NPY
10-8 M 10-10 M 10-12 M 10-8 M
fMLF 179.18a 160.36a 140.83a 113.33
(4.99) (3.80) (5.22) (6.64)
Human PMNs (105 cells/well) were incubated in the presence of 0.2 μM of fMLF and
to 30 min using Berthold Microlumat luminometer. Values are expressed as relative
maximal CL increase (PHCL). The presented results are means ± (SEM) of three indep
from fMLF-stimulated ROS increase (a p< 0.0005; b p< 0.001; c p< 0.05) as determiantimicrobial activity enhanced by chemiotherapeutics.
The alliance between the cationic peptide magainin II and
the betalactam antibiotics against Pseudomonas aerugi-
nosa [52] may be an example of such synergism. However,
the potential role of synergistic reactions between neuro-
peptides and others antimicrobials remains to be
determined.
The direct antibacterial potential of substance P against
laboratory strains of E. coli, P. aeruginosa, P. vulgaris,
E. faecalis, and S. aureus was firstly reported in 2002 using
the microdilution broth method [21]. Conversely, in 2006,
using radial diffusion assay, it was demonstrated a lack of
the antibacterial effect of substance P and neuropeptide Y
on laboratory strains of S. aureus and P. aeruginosa [22].
Recently, antimicrobial activities of various neuropeptides
against a wide range of laboratory microorganisms (S.
mutans, L. acidophilus, E. coli, E. faecalis, P. aeruginosa,
C. albicans) typical for skin, oral cavity, respiratory tract
and gastrointestinal tract has been reported [23]. These
discrepancies may be the result of different susceptibilities
of strains used in the above studies, as many human cat-
ionic peptides demonstrate a strain-selective activity
against microorganisms [53]. Another reason may be the
different detection limits of particular methods employed.
For example, a radial diffusion assay showed the resistance
of Porphyromonas gingivalis ATCC 49417 strain to β-
defensins [53], whereas a microtiter method and a DNA
binding dye demonstrated its sensitivity to the same anti-
microbials [54]. It has been demonstrated that subtleROS generation by PMNs in luminol-dependent
CGRP
10-10 M 10-12 M 10-8 M 10-10 M 10-12 M
136.04a 129.67c 266.41a 164.35a 153.47b
(3.91) (3.26) (8.37) (13.47) (1.5)
three concentrations of each NPs and chemiluminescence was measured up
changes from controls (PMNs + fMLF) and were calculated based on the
endent experiments performed at least in triplicate. a-c Significantly different
ned by Tuckey’s post hock test.
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about marked differences in their activity [48]. Our results
seem to confirm that explanation, since, unlike the liquid
broth time kill assay in which 100 μM CGRP, NPY, and SP
displayed killing activity against ~2 × 106 CFU/ml of
selected clinical isolates, such activity against the same
bacterial load was not observed, when using a radial diffu-
sion assay.
Using the data for the peptides analyzed in this paper
and by other authors [21,23] we assessed the relation-
ships between direct antibacterial activities of these pep-
tides and their physicochemical properties as well as the
amino acid composition deduced from their sequences.
The performed meta-analyses revealed statistically sig-
nificant relationships between many analyzed para-
meters. These relationships did not always show
consistent trends for all considered experiments and
seemed to depend rather on the tested set of peptides
than the studied bacterial species or strains. The non-
universality of these tendencies and its dependence on
peptide sets may indicate that a similar antimicrobial ac-
tivity can be achieved by peptides with different charac-
teristics or that variable degree of this activity is exerted
by the same peptide due to various experimental condi-
tions applied for different bacterial species tested (e.g.
properties of their envelopes). It is also likely that the
antibacterial activity of peptides results from a superpos-
ition of many physicochemical properties, whose contri-
bution to and influence on this activity may be different
in various antimicrobial peptides that fold into different
structures. Therefore, some observed specificities of NPs
may result from their potential ability to form other
bonds which are specific in each particular peptide-
membrane system. These bonds, such as for example
hydrogen bonds, are likely to cause specific configur-
ational and conformational modification of lipid bilayer
and the membrane proteins, respectively. All mentioned
above consequences of the bonds may change the anti-
bacterial peptide capacity. Our observations confirm that
peptide-membrane interactions are determined by a sen-
sitive balance of electrostatic and hydrophobic interac-
tions in which the universal, simple correlation between
antimicrobial activity and specified structural feature of
peptide is seldom demonstrated [45]. More extensive
studies on the antimicrobial potency of many peptides
under the same experimental conditions are necessary to
evaluate more precisely the relationships between their
activities and physicochemical features.
Polymorphonuclear neutrophils are the first leukocyte
population that comes to the site of inflammation and
play a key role in the eradication of invading pathogens.
The next focus of our study was therefore on the immu-
nomodulatory effects of NPs on important steps of gran-
ulocyte phagocytosis. We addressed the question whethergranulocyte-mediated uptake and the generation of oxy-
gen radicals during phagocytosis of M. catarrhalis and H.
influenzae was modulated by NPY, SP, CGRP and if such
modulation involved distinct types of pathogen recogni-
tion. As expected, precoating with serum immunoglobu-
lins significantly enhanced the phagocytic uptake by
PMNs and the ability of bacterial stimuli to release ROS
from human PMNs. Next, we found that all the studied
NPs accelerate the phagocytic uptake of both mucosal
pathogens but only in the presence of specific opsonins,
whereas the stimulatory effect of NPs was not observed in
their absence. Thus, the effect of NPs seems to be additive
with that produced by opsonized bacteria.
Unlike phagocytic uptake, the results of the NPs impact
on bacteria-stimulated ROS response showed quite differ-
ent modulatory effect. We reported that NPs stimulated
the respiratory burst of PMNs in the absence of opso-
nins while reducing oxidative burst in response to serum-
treated bacteria. Under the conditions of our assays, this
effect appeared to be not restricted to M. catarrhalis-
induced response, since response to NTHi was also
diminished. The finding that NPs increase the uptake of
opsonized bacteria without the intensifying the respiratory
burst suggests that NPs may promote bacterial uptake
without exacerbating oxidant release. It follows therefore
that the NP-mediated amplification of bacteria-stimulated
redox metabolism of PMNs, which is required for the gen-
eration of bactericidal oxygenating agents, may be attribu-
ted only to the initial phagocytic response against the
studied bacteria, that do not involve antibody cooperation.
In fact, cationic peptides, found to be critical for the
interaction with endotoxin, could directly enhance ROS
amplification by pathogen opsonization or by exerting
synergistic effect together with endotoxin [55,56]. Add-
itionally, the insensitivity of the opsonin-dependent ROS
response to NPs may indicate that its origin is probably
not connected to Ig-dependent signaling. These findings
strengthen the observation of bimodal action of NPY [8]
and probably other NPs. Furthermore, they suggest that
depending on the different receptor interplay, an efficient
pathogen uptake and their effective elimination may be
provided. These results also suggest that the increase in
NP-mediated bacterial uptake and the ROS formation in
the response to bacterial stimuli are separate and distin-
guishable characteristics of PMNs.
Although demonstrating the modulation of phagocytic
PMNs activity by NPY, SP, and CGRP, the receptors me-
diating these effects were not identified in our study.
However, the expression of SP (NK1, NK2, NK3) and
NPY (Y1, Y2, Y4, Y5), membrane specific receptors on
human PMNs, was previously confirmed by both mo-
lecular and pharmacological approach. Furthermore, it
has been shown that SP and NPY had regulatory effect on




























































































































Figure 5 Influence of neuropeptides on ROS generation by human PMNs. Human PMNs (105/well) were added to ~107 CFU of
nonopsonized or 10% heat-inactivated serum-opsonized M. catarrhalis ATCC 25238 (Mc) or nontypeable H. influenzae ATCC 49247 (NTHi) or to
wells without bacteria in the presence or absence of 10−8 M of given neuropeptides and luminol-dependent chemiluminescence was measured
up to 60 min using Berthold Microlumat luminometer. (A) Kinetics of ROS generation in human PMNs in response to bacterial stimulation in the
absence of NPs. The results are expressed as mean relative light units/sec (RLU/s). The representative experiment performed in triplicate is shown
(B) Histograms represent the AUCCL (mean ± SD) of at least 3 independent experiments done in triplicate from different donors. Results are
expressed as a percentage of the PMN response stimulated only with bacteria. Asterisks indicate statistically significant differences calculated with
reference to relevant controls if *p ≤ 0.05 and **p< 0.0005 (one-way ANOVA followed by Duncan’s post hock test).
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http://www.biomedcentral.com/1471-2172/13/24[8,57]. It is difficult to explain why the stimulatory phago-
cytic effect of NPs was exerted during the opsonin-
dependent uptake as well as the opsonin-independent
ROS response. The underlying mechanisms for these
contradictory effects were not further explored in this
study. At present, we can only speculate that the IgG-FcγR
interaction favors signals triggered by NPs, whereas CEA-
CAM3 (the opsonin-independent phagocytic receptor that
functions specifically in the recognition and clearance of
M. catarrhalis and nontypable H. influenzae by human
granulocytes [58]) as well as other innate receptors such
as TLR4, exert the opposite effect. Receptors often func-
tion cooperatively during microbial uptake and many par-
allel signaling pathways are simultaneously activated [59].
Furthermore, because signaling during phagocytosis may
vary in response to signals from other receptors, it can
modify the activation state of the phagocyte [60]. We pos-
tulate from this finding that even if a successful engulf-
ment of mucosal pathogens by PMNs involves distinct
types of pathogen recognition, the opsonin-dependent
pathway seems to be the most relevant in view of the
enhanced uptake elicited by neuropeptides. Our results
are in partial agreement with the previous data on stimu-
latory action of NPY against E. coli, although it was tested
only in opsonic conditions [8].
Unlike the confirmed presence of SP and NPY recep-
tors on PMNs, the data from the literature do not sup-
port the presence of functional CGRP-specific receptors
on mature granulocytes [61]. Thus, the fact that both
critical phagocytic steps of PMNs, namely the engulf-
ment and the ROS generation, were considerably inten-
sified in the presence of CGRP was an unexpected
finding. A lack of functional CGRP receptors on the sur-
face of PMNs does not preclude the involvement of
other mechanism of CGRP action such as non-specific
receptor usage. It was demonstrated that CGRP may en-
hance phagocytosis as a result of the engagement of
phagocytic mannose-receptors [46]. A direct activation
of PMNs by CGRP has been additionally reported [62].
Further studies are necessary to find out what mechan-
isms underline the CGRP-mediated stimulation of PMN
phagocytosis. Summing up, the contradictory action of
NPs on M. catarrhalis and H. influenzae engulfment
and ROS response by human PMNs seems to be deter-
mined both by the nature of pathogen recognition and
by the physiological status of PMN donor. This type of
bimodal effect has been reported for various neuropep-
tides as well as various concentrations of the same
neuropeptide on phagocytosis, reactive oxygen produc-
tion, phagocytic cell adherence and migration or cyto-
kine release [8,63].
In conclusion, we established a direct antibacterial ac-
tion of CGRP, NPY, SP, and SOM against M. catarrhalis
and nontypeable H. influenzae as well as (apart fromSOM) indirect antibacterial effect of the neuropeptides
through immunomodulation of PMN phagocytosis.
Therefore, CGRP, NPY, and SP, seem to be important
molecules involved in innate host defense against M.
catarrhalis and in part also against nontypeable H. influ-
enzae. In higher concentrations they are bactericidal,
whereas in lower, physiologically relevant doses, they show
immunomodulating properties. The finding regarding the
relevance of 10−8 M and lower NPs doses may have.
physiological or clinical implications. Substance P, NPY,
and CGRP may induce chemotaxis of neutrophils, mono-
cytes and macrophages [64,65], therefore attract phago-
cytic cells to the site of infection. The NPY can modulate
critical phagocytic function of PMNs including engulf-
ment and ROS production [8]. Substance P may signifi-
cantly induce an expression of cyclooxygenase-2, an
activation of nuclear factor NF-κβ, and release of prosta-
glandin PGE2 from PMNs [57], as well as trigger mast
cells priming and degranulation [66,67], all leading to an
inflammatory response. In the context of adaptive immun-
ity, the SP-mediated release of IgG1, IgG3, and IgG4 sub-
classes implicates its possible importance in antibody-
mediated responses during infection [68]. Furthermore,
CGRP, NPY, SP, and SOM can also directly affect T cell
functions, as they can modulate T cell migration [69] or
induce secretion of cytokines such as IL-2, IFN-γ, IL4, and
IL-10 by Th1 and Th2 cells in response to antigenic
stimulation [3]. All these events may contribute to the
local antimicrobial activity of neuropeptides in vivo.
It is noteworthy that low NP levels may act in concert
with other inflammatory mediators. Such synerginistic
response of low SP doses under stimulation with LPS
has been shown to potentiate the neutrophil adherence
to epithelial cells and cytokine release [70]. NPY and SP
can also activate epithelial cells to produce other antimi-
crobials such as cathelicidins or β-defensins [2] whose
bactericidal activities against M. catarrhalis and non-
typeable H. influenzae have been documented [71]. Our
observations expand on the previous findings for NPY,
CGRP, SP, and are new in the case of SOM direct in-
volvement in antibacterial innate immunity. They show
also that neuropeptide-dependent modulation of phago-
cytosis of the respiratory pathogens under study is a bi-
directional phenomenon. However, further research is
needed to provide the insight into the particular
mechanisms of NPs action and their real clinical signifi-
cance in the microbial diseases caused by M. catarrhalis
and H. influenzae.
Conclusion
The present results indicate that neuropeptides such as
CGRP, NPY, and SP can effectively participate in the dir-
ect and indirect (immunomodulating) elimination of
human-specific respiratory pathogens and seem to be
Augustyniak et al. BMC Immunology 2012, 13:24 Page 16 of 17
http://www.biomedcentral.com/1471-2172/13/24important molecules involved in the innate host defense
against M. catarrhalis and nontypeable H. influenzae.
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